Featured Research

from universities, journals, and other organizations

Next steps in potential stem cell therapy for diabetes: Study looks at differentiation of hESCs in endocrine cell progression

Date:
January 10, 2013
Source:
University of California - San Diego
Summary:
Researchers looked at the differences and similarities between two types of hESC-derived endocrine cell populations and primary human endocrine cells, with the longer-term goal of developing new stem cell therapies for diabetes.

Type 1 and type 2 diabetes results when beta cells in the pancreas fail to produce enough insulin, the hormone that regulates blood sugar. One approach to treating diabetes is to stimulate regeneration of new beta cells.

There are currently two ways of generating endocrine cells (cell types, such as beta cells, that secrete hormones) from human embryonic stem cells, or hESCs: either generating the cells in vitro in culture or transplanting immature endocrine cell precursors into mice.

Researchers from the University of California, San Diego School of Medicine, collaborating with scientists from San Diego-based biotech company ViaCyte, Inc., looked at the differences and similarities between these two types of hESC-derived endocrine cell populations and primary human endocrine cells, with the longer-term goal of developing new stem cell therapies for diabetes.

The results of their study will be published on line January 10, in advance of the February 7 print edition of the journal Cell Stem Cell.

The scientists compared gene expression and chromatin architecture -- the structure of combined DNA and proteins that make up the nucleus of the cell, in which dynamic remodeling occurs at various stages of differentiation -- in both primary human endocrine cells and hESC-derived cells.

"We found that the endocrine cells retrieved from transplanted mice are remarkably similar to primary human endocrine cells," said principal investigator Maike Sander, MD, professor of pediatrics and cellular and molecular medicine, and director of UC San Diego's Pediatric Diabetes Research Center. "This shows that hESCs can differentiate into endocrine cells that are almost indistinguishable from their primary human counterparts."

However, the researchers observed that endocrine cells produced in vitro lack features of primary endocrine cells and fail to express the majority of genes that are critical for endocrine cell function. Consistent with this finding, these cells are not able to reverse diabetes in diabetic animal models.

Sander explained that one way to move forward with cell replacement therapies for diabetes is to transplant the endocrine precursor cells into humans and let the cells mature in the patient as they do in mice. "However, we don't currently know whether the maturation process will occur in humans in the same way."

She added that an alternative approach is to generate fully functional endocrine cells in the culture dish and to then transplant these cells into humans. While such a method of generating functional endocrine cells in the dish does not yet exist, this study provides hints about the steps currently missing in in vitro differentiation protocols.

Sander and colleagues identified a key mechanism for the induction of developmental regulators -removal of a family of proteins that can remodel chromatin called the Polycomb group (PcG). Reinstating PcG-dependent repression silenced the expression of genes that are only temporarily activated, and need to be turned off in order for cells to progress to their final differentiated endocrine state. When endocrine cells were produced in the culture dish, the researchers found that PcG-mediated repression was not fully eliminated, probably contributing to the cells' malfunction.

"This information will help devise protocols to generate functional insulin-producing beta cells in vitro," said Sander. "This will be important not only for cell therapies, but also for identifying disease mechanisms that underlie the pathogenesis of diabetes."

Additional contributors to the study include first author Ruiyu Xie, Nisha A. Patel and Allen Wang, UC San Diego; Logan J. Everett, Hee-Woong Lim, Jonathan Schug, Kyoung-Jae Won and Klaus H. Kaestner, Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania; and Evert Kroon, Olivia G. Kelly, Kevin A. D'Amour and Allan J. Robins, ViaCyte Inc., San Diego.

This work was supported by National Institutes of Health grants U01-DK089567, R01-DK07243, U01-DK089529, R01-DK088383 and P30-DK19525.


Story Source:

The above story is based on materials provided by University of California - San Diego. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ruiyu Xie, Logan J. Everett, Hee-Woong Lim, Nisha A. Patel, Jonathan Schug, Evert Kroon, Olivia G. Kelly, Allen Wang, Kevin A. D’Amour, Allan J. Robins, Kyoung-Jae Won, Klaus H. Kaestner, and Maike Sander. Dynamic Chromatin Remodeling Mediated by Polycomb Proteins Orchestrates Pancreatic Differentiation of Human Embryonic Stem Cells. Cell Stem Cell, 2013; DOI: 10.1016/j.stem.2012.11.023

Cite This Page:

University of California - San Diego. "Next steps in potential stem cell therapy for diabetes: Study looks at differentiation of hESCs in endocrine cell progression." ScienceDaily. ScienceDaily, 10 January 2013. <www.sciencedaily.com/releases/2013/01/130110121022.htm>.
University of California - San Diego. (2013, January 10). Next steps in potential stem cell therapy for diabetes: Study looks at differentiation of hESCs in endocrine cell progression. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2013/01/130110121022.htm
University of California - San Diego. "Next steps in potential stem cell therapy for diabetes: Study looks at differentiation of hESCs in endocrine cell progression." ScienceDaily. www.sciencedaily.com/releases/2013/01/130110121022.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy
Powered by NewsLook.com
Thousands Who Can't Afford Medical Care Flock to Free US Clinic

Thousands Who Can't Afford Medical Care Flock to Free US Clinic

AFP (July 23, 2014) America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th. Thousands turned out for a free clinic run by "Remote Area Medical" with a visit from the Governor of Virginia. Duration: 2:40 Video provided by AFP
Powered by NewsLook.com
Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins